Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2

Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2

Thumbnail Image
Download
Name

Yaffe_Synergistic innate.pdf

Size

3.36 MB

Format

Adobe PDF

Checksum (MD5)

904e0ca6cce13b63f89e8fc9e280e07b

Author(s)
Surana, Rishi
•
Mihm, Martin C.
•
Angelini, Alessandro
•
Weiner, Louis M.
•
Dranoff, Glenn
•
Zhu, Eric Franklin
•
Opel, Cary Francis
•
Kwan, Byron Hua
•
Kauke, Monique Jacqueline
•
Moynihan, Kelly Dare
more
Date Issued
April 2015
Journal
Cancer Cell
Publisher
Elsevier
Citation
Zhu, Eric F. et al. “Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2.” Cancer Cell 27.4 (2015): 489–501.
Version
Author's final manuscript
Abstract
Cancer immunotherapies under development have generally focused on either stimulating T cell immunity or driving antibody-directed effector functions of the innate immune system such as antibody-dependent cell-mediated cytotoxicity (ADCC). We find that a combination of an anti-tumor antigen antibody and an untargeted IL-2 fusion protein with delayed systemic clearance induces significant tumor control in aggressive isogenic tumor models via a concerted innate and adaptive response involving neutrophils, NK cells, macrophages, and CD8+ T cells. This combination therapy induces an intratumoral “cytokine storm” and extensive lymphocyte infiltration. Adoptive transfer of anti-tumor T cells together with this combination therapy leads to robust cures of established tumors and development of immunological memory.
MIT Department
Massachusetts Institute of Technology. Center for Materials Science and Engineering
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Biology
Massachusetts Institute of Technology. Department of Chemical Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
http://creativecommons.org/licenses/by-nc-nd/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/105835
DOI of Published Version
https://doi.org/10.1016/j.ccell.2015.03.004
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.